We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

September 22, 2010

Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. February 12, 2013

    Judge Invalidates Bristol-Myers Patent For Hepatitis B Drug

    A Delaware federal judge on Monday struck down a Bristol-Myers Squibb Co. patent on the hepatitis B drug Baraclude as obvious, a ruling in favor of generic drugmaker Teva Pharmaceutical Industries Ltd., which had challenged the patent's validity.


To view the parties, register now.